Fortunately, scientists at the Life & Brain Research Center and the Clinic for Neurology at the University of Bonn have discovered a way to work around the problem. By taking skin cells from patients with a genetic movement disorder and reprogramming them into so-called induced pluripotent stem cells, researchers were able to create functional neurons that allowed them to investigate the causes of the disease. Their results will be published in the journal Nature.
The focus of the Bonn study is Machado-Joseph disease, which affects people’s ability to coordinate movement. First identified among Portuguese descendants living on the Azores, today it represents the most frequent dominantly inherited cerebellar ataxia in Germany. Most patients first develop symptoms, which include difficulty walking and other neurological difficulties, between the ages of 20 and 40. The cause of the disorder is a repeating sequence in the ATXN3 gene, which causes build-up of the Ataxin protein, damaging neurons in the brain. Before the study, no one knew why the disease affected only nerve cells and what triggered the abnormal protein build-up.
“Master Cells” derived from patient skin samples
To study the disease process on a molecular level, the stem cell researcher Dr. Oliver Brüstle and his team at the University of Bonn’s Institute for Reconstructive Neurobiology derived induced pluripotent stem cells (iPS cells) from small samples of patient skin. iPS cells are cells restored to their early, undifferentiated state. Once “reprogrammed,” these “master” cells divide continuously and can transform into any cell of the body. In a subsequent step, Brüstle and his team converted iPS cells into brain stem cells, creating an ever-ready supply of neurons for their investigations.
A special feature of the neurons is that they stem from affected patients. Carrying the same genetic mutations as the patients, these neurons can serve as a cellular model for Machado-Joseph disease. “This method allows us to investigate diseased cells which we otherwise couldn’t access, almost as if we had put the patient’s brain in a Petri dish,” says Dr. Philipp Koch, a long-time colleague of Brüstle’s and one of the study’s primary authors. Together with Dr. Peter Breuer of the Clinic for Neurology at Bonn’s University Hospital, Koch sent electrical currents through the cultured neurons. The researchers showed that the formation of protein aggregate has a direct relationship with a neuron’s electrical activity. “Playing a key role is the enzyme calpain, which is activated by the increased calcium levels in stimulated neurons,” says Breuer. “This newly discovered mechanism explains why Machado-Joseph disease only affects neurons,” Brüstle explains.
Reprogramed neurons as test objects for new drugs
“The study shows the potential of this special class of stem cells for neurological research,” says Prof. Dr. Thomas Klockgether, the clinical director of the German Center for Neurodegenerative Diseases (DZNE) and director of the Clinic for Neurology at the Bonn’s University Hospital. Klockgether’s team closely collaborated with Brüstle and his researchers. For Brüstle, this was reason enough to start thinking about new organizational structures: “We need interdisciplinary departments in which scientists from stem cell biology and from molecular pathology work side by side.” Prof. Dr. Dr. Pierluigi Nicotera, the scientific director and chairman of the executive board of DZNE, endorses this view. “Cooperative structures are of great interest to DZNE,” he stresses. “Reprogramed stem cells show enormous potential for our understanding of the pathology of neurodegenerative diseases.”
In the future, Brüstle and his colleagues from the Life & Brain Research Center plan to use reprogrammed neurons to develop treatments for neurological diseases.Publication:
Daniel Bayer | idw
Further reports about: > Brain Research > DZNE > Forum Life Science > Machado-Joseph disease > Nature Immunology > Neurology > Reconstructive > calcium level > degenerative Erkrankung > degenerative disease > genetic mutation > iPS cells > induced pluripotent stem > induced pluripotent stem cell > nerve cell > neurodegenerative disease > neurological disease > pluripotent stem > pluripotent stem cells > skin cell > stem cells
Discovery of genes involved in the biosynthesis of antidepressant
09.12.2019 | Leibniz Institute of Plant Genetics and Crop Plant Research
Scientists have spotted new compounds with herbicidal potential from sea fungus
09.12.2019 | Far Eastern Federal University
Using a clever technique that causes unruly crystals of iron selenide to snap into alignment, Rice University physicists have drawn a detailed map that reveals...
University of Texas and MIT researchers create virtual UAVs that can predict vehicle health, enable autonomous decision-making
In the not too distant future, we can expect to see our skies filled with unmanned aerial vehicles (UAVs) delivering packages, maybe even people, from location...
With ultracold chemistry, researchers get a first look at exactly what happens during a chemical reaction
The coldest chemical reaction in the known universe took place in what appears to be a chaotic mess of lasers. The appearance deceives: Deep within that...
Abnormal scarring is a serious threat resulting in non-healing chronic wounds or fibrosis. Scars form when fibroblasts, a type of cell of connective tissue, reach wounded skin and deposit plugs of extracellular matrix. Until today, the question about the exact anatomical origin of these fibroblasts has not been answered. In order to find potential ways of influencing the scarring process, the team of Dr. Yuval Rinkevich, Group Leader for Regenerative Biology at the Institute of Lung Biology and Disease at Helmholtz Zentrum München, aimed to finally find an answer. As it was already known that all scars derive from a fibroblast lineage expressing the Engrailed-1 gene - a lineage not only present in skin, but also in fascia - the researchers intentionally tried to understand whether or not fascia might be the origin of fibroblasts.
Fibroblasts kit - ready to heal wounds
Research from a leading international expert on the health of the Great Lakes suggests that the growing intensity and scale of pollution from plastics poses serious risks to human health and will continue to have profound consequences on the ecosystem.
In an article published this month in the Journal of Waste Resources and Recycling, Gail Krantzberg, a professor in the Booth School of Engineering Practice...
03.12.2019 | Event News
15.11.2019 | Event News
15.11.2019 | Event News
09.12.2019 | Earth Sciences
09.12.2019 | Information Technology
09.12.2019 | Life Sciences